Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…
MSD (Merck & Co., Inc.)
(https://msd.com) 📸 Data Snapshot: May 31, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE MSD | Home (https://msd.com)
Title
MSD | Home
Meta
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
H2 What can we help you find?
H2 Advancing the future of cancer research
H2 Explore our stories
H2 Related links
H3 Patients
H3 Investors
H3 Sustainability
H3 About us
H3 Pipeline
H3 Clinical trials
H3 Connect with us on social
H3 Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA
H4 Who we are
NAV_HEADER_HEADING_REPEATED_BODY Who we are – MSD (https://msd.com/company-overview/)
Title
Who we are – MSD
Meta
MSD aspires to be the premier research-intensive biopharmaceutical company in the world. Learn about our commitment to save and improve lives.
H1 Who we are
H2 What can we help you find?
H2 Our purpose: We use the power of leading-edge science to save and improve lives around the world
H2 Our values
H2 Diversity and inclusion
H2 Leadership
H2 Patients and caregivers
H2 Learn more about who we are
H2 Related links
H3 We're driven by a desire to improve life
H3 We strive to provide equal opportunity for all
H3 The team that guides our passion
H3 Everything that motivates us starts with you
H3 Read our stories
H3 What we do
H3 Connect with us on social
H3 Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA
H4 Who we are
H5 What are individualized neoantigen therapies?
H5 MSD and City Cancer Challenge expand global partnership to strengthen women’s cancer care
H5 MSD for Mothers: Expanding access to quality maternal care
H5 Know your risk for bladder cancer — and don’t ignore the signs
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER Sustainability – MSD (https://msd.com/company-overview/sustainability/)
Title
Sustainability – MSD
Meta
MSD corporate responsibility is about the health, social, environmental and economic impact on people and communities around the world.
H1 Sustainability
H2 What can we help you find?
H2 Sustainability is core to how we do business
H2 Watch: Our company’s impact
H2 Our impact by the numbers
H2 Related links
H3 Access to health
H3 Employees
H3 Environmental sustainability
H3 Ethics and values
H3 Stories showing our impact
H3 Connect with us on social
H3 Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA
H4 Who we are
H5 Philanthropy
H5 Impact Venture Fund
H5 Sustainability resources
H5 Transparency disclosures
H5 MSD publishes Purpose for Progress Impact Report 2024/2025
H5 We’re ‘seeing green’ and building a more sustainable business
H5 MSD for Mothers: Expanding access to quality maternal care
H5 How we’re addressing health literacy
H5 35 Years: The Mectizan® Donation Program
NAV_HEADER_HEADING_REPEATED_BODY Media – MSD (https://msd.com/media/)
Title
Media – MSD
Meta
MSD's online newsroom offers real-time news about MSD's prescription medicines, vaccines and consumer care products.
H1 Media
H2 What can we help you find?
H2 Media contact details
H2 Media library
H2 MSD corporate and product multimedia
H3 Corporate brand
H3 Leadership
H3 Manufacturing
H3 Headquarters, research and manufacturing
H3 Vaccine production
H3 Get to know us through our stories
H3 We are driven by a single purpose
H3 Pipeline
H3 Company fact sheet
H3 Connect with us on social
H3 Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA
H4 Who we are
H5 MSD logo
H5 Robert M. Davis
H5 Automated visual inspection of filled vials
H5 Automated visual inspection of filled vials
H5 B-roll package
H5 B-roll package
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://msd.com) MSD | Home
[IMG: Pause video] [IMG: Play video] [H2] Advancing the future of cancer research Learn more about our work [H2] [IMG: man holding wife] [H3] Patients We’re here to help you get the information you need to guide you on your health journey. [IMG: Woman scientist injecting solution into test tube] [H3] Investors Find our latest financials, events and presentations, news, stock information and investor contacts. [IMG: Split image showing a gloved hand holding a petri dish with greenish-blue microbial colonies on the left, and an artistic Earth covered in green foliage and blue oceans on the right] [H3] Sustainability We operate responsibly every day to enable a safe and healthy future for people and communities globally. [H2] Explore our stories [IMG: Image for Innovation] Innovation How MSD scientists are driving next-generation cancer research [IMG: Image for Innovation] Innovation What are individualized neoantigen therapies? [IMG: Image for Innovation] Innovation We're pursuing innovative science with antibody-drug conjugate (ADC) research [IMG: Image for Innovation] Innovation Exploring KRAS: A precision approach in oncology 1 Read more stories [H2] [IMG: Scientist reviewing test tubes] [H3] About us For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. Who we are What we do × [IMG: two scientists working in a lab] [H3] Pipeline We follow the science where we can make the greatest difference, now and in the future. Pipeline × [IMG: Woman with glases ponders] [H3] Clinical trials Clinical trials help find new treatments to help save and improve lives. Our progress is due in large part to the important and tough scientific questions we set out to answer with our trials and collaborations. Learn more about clinical trials ×
2120 chars
SUB-PAGE (https://msd.com/company-overview/) Who we are – MSD
[IMG: researcher in lab] [H1] Who we are We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. [H2] Our purpose: We use the power of leading-edge science to save and improve lives around the world For more than 130 years, we’ve brought hope to humanity through the development of important medicines and vaccines. We foster an inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. Our values | Diversity and inclusion | Leadership I Patients [H2] Our values We hold ourselves to the highest standards of ethics and integrity. [IMG: Employees riding bikes] [H3] We're driven by a desire to improve life Our values represent the core of our character and guide every decision and action we take. Patients first Respect for people Ethics and integrity Innovation and scientific excellence Learn more about our culture and values × [H2] Diversity and inclusion We recognize the importance of embedding a culture of inclusion and belonging at every level of our company. We’re committed to fostering an environment of engagement and empowerment. [IMG: group of people talking] [H3] We strive to provide equal opportunity for all An inclusive mindset is central to our business growth and enables us to ensure patients and customers experience ultimate health outcomes. Learn more about our diversity and inclusion efforts × [H2] Leadership Our leaders guide our purpose to use the power of leading-edge science to save and improve lives around the world. This is the foundation of everything we do. [IMG: illustration of leadership speaking panel] [H3] The team that guides our passion Our leaders come from all areas of the business to help position us to succeed. Meet our leadership team × [H2] Patients and caregivers We work hard to bring you the medications and vaccines that help fight some of the world’s most serious health concerns. [IMG: man holding wife] [H3] Everything that motivates us starts with you We’re here to help you get the information you need to guide you on your health journey. Learn more about our commitment to patients × [H2] Learn more about who we are [H3] Read our stories Learn about the heartbeat of our company. [IMG: Image for What are individualized neoantigen therapies?] [H5] What are individualized neoantigen therapies? How scientists are harnessing the specific mutations of each person’s cancer to evaluate therapies that would be tailored to their own tumor [IMG: Four women crossing a city street] [H5] MSD and City Cancer Challenge expand global partnership to strengthen women’s cancer care This initiative aims to reach more than 300,000 women living with cancer around the world by 2030 [IMG: woman smiling and holding a smiling infant] [H5] MSD for Mothers: Expanding access to quality maternal care More than a decade of strategic partnerships, private sector innovation and data-driven impact to help create a world where no woman has to die while giving life [IMG: 3 people conversing] [H5] Know your risk for bladder cancer — and don’t ignore the signs Awareness gaps can impact recognition and diagnosis of bladder cancer [IMG: Pause] [IMG: Play] [IMG: Featured banner image] [H3] What we do We use the power of leading-edge science to save and improve lives around the world. Learn more
3748 chars
SUB-PAGE (https://msd.com/company-overview/sustainability/) Sustainability – MSD
[IMG: Split image showing a gloved hand holding a petri dish with greenish-blue microbial colonies on the left, and an artistic Earth covered in green foliage and blue oceans on the right] [H1] Sustainability We operate responsibly every day to improve human and animal health, now and in the future. Purpose for Progress Impact Report 2024/2025 Purpose for Progress Report Summary 2024/2025 [H2] Sustainability is core to how we do business From expanding access to care to advancing environmental goals, our Purpose for Progress: MSD Impact Report 2024/2025 shows how our company is creating measurable impact — for people, communities and the planet. The name reinforces how our purpose serves as a compass and guides us in our every endeavor. Because progress doesn’t just happen. It’s built — by people, with purpose. Jump to: Access to health | Employees | Environmental sustainability | Ethics and values [H2] Watch: Our company’s impact [IMG: Collage of photos] [H2] Our impact by the numbers Access to health >450M People reached with our medicines and vaccines in 2024. Employees >25K Members of at least one of our 10 employee business resource groups — almost 30% of our workforce globally. All employees are welcome to join any group. Environmental sustainability 2045 Target date for achieving net-zero greenhouse gas emissions across our global operations (Scopes 1, 2, and 3), aligned with the guidelines of the Science-Based Targets initiative. Ethics and values 24/7 Availability of our ethics reporting tool, which allows employees and third parties to raise concerns confidentially and anonymously (where permitted by law). [IMG: Group of doctors consulting their patients] [H3] Access to health Health breakthroughs matter most when they reach the people who need them. In 2024, we reached 92% of the world’s countries with our products. Fact sheet: Our impact by the numbers Infographic: Expanding access to health Learn more about our approach to access × [IMG: Two employees outside talking] [H3] Employees Our people are at the heart of our purpose. In 2024, our employees dedicated more than 3 million hours to learning — from hands-on training to leadership development. We’re investing in growth, well-being and opportunity so every employee can lead with purpose and shape what’s next. Employees at a glance: Fact sheet: Our workforce by the numbers Infographic: Empowering employees through learning and development Learn more about who we are × [IMG: parent and child picking flowers] [H3] Environmental sustainability We’re working toward a future where people and the planet can thrive. We’ve committed to sourcing 100% of our purchased electricity from renewable energy by 2025. It’s all part of our journey to net zero. Environmental sustainability at a glance: Fact sheet: Our environmental sustainability impact by the numbers Infographic: Powering health starts with a healthy planet Learn more about our efforts × [IMG: Two employees riding bicycle outside] [H3] Ethics and values We’re guided by values and driven by integrity. In 2024, more than 99% of employees completed ethics training, and we spent $4 billion with small Tier 1 and 2 suppliers globally, fostering a healthy supply chain. It’s how we earn trust, every day, everywhere we work. Ethics and values at a glance: Fact sheet: Our commitment to ethics by the numbers Infographic: Speak up – Powering a culture of integrity Learn about our values × [IMG: doctor with child] [H5] Philanthropy We provide financial and product donations to help advance health equity, support local communities and address critical social needs. Explore more [IMG: Healthcare professional comforting pregnant women] [H5] Impact Venture Fund We invest in funds and companies working to improve access to health and, in turn, create financial returns and strategic opportunities for our company. Learn more [IMG: Our-Employees-UG-Walking-Hallway] [H5] Sustainability resources Our reports, policies, resources and guidelines govern the work we do every day. Learn more [IMG: colleagues sitting together] [H5] Transparency disclosures We aspire to be transparent about how we operate to earn the trust and confidence of our customers and other stakeholders. Explore more [H3] Stories showing our impact [IMG: Split image showing a gloved hand holding a petri dish with greenish-blue microbial colonies on the left, and an artistic Earth covered in green foliage and blue oceans on the right] [H5] MSD publishes Purpose for Progress Impact Report 2024/2025 Our company’s purpose is to use the power of leading-edge science to save and improve lives around the world. This purpose serves as our compass and guides us every day. Our Purpose for Progress: MSD 2024/2025 Impact Report provides a comprehensive view of how we’re pursuing innovative science for the health of people and animals […] [IMG: Group of people working together] [H5] We’re ‘seeing green’ and building a more sustainable business Our award-winning ‘See Green, Be Green’ sustainability initiative exemplifies our company's and employees' commitment to operating responsibly [IMG: woman smiling and holding a smiling infant] [H5] MSD for Mothers: Expanding access to quality maternal care More than a decade of strategic partnerships, private sector innovation and data-driven impact to help create a world where no woman has to die while giving life [IMG: Senior couple reviewing medical information with a health care provider] [H5] How we’re addressing health literacy Many people struggle to understand health information, which can impact health outcomes. What we're doing to support health literacy. [IMG: Mectizan hero] [H5] 35 Years: The Mectizan® Donation Program The Mectizan Donation Program is the longest-running, disease-specific drug donation program of its kind [IMG: Pause] [IMG: Play]
6238 chars
SUB-PAGE (https://msd.com/media/) Media – MSD
[IMG: Outside of corporate building with blue windows] [H1] Media Our media contacts and multimedia resources News releasesCompany statements April 30, 2026 Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones February 3, 2026 Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline October 30, 2025 Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results View all May 8, 2026 MSD Statement on Daiichi Sankyo Update to Manufacturing and Supply Plan May 7, 2026 MSD Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate May 5, 2026 MSD Completes Acquisition of Terns Pharmaceuticals, Inc. April 22, 2026 MSD and Google Cloud Partner to Accelerate Agentic AI Enterprise Transformation April 2, 2026 MSD Announces Initiation of Pivotal Phase 2b/3 Trial Evaluating MK-8748 (Tiespectus), an Investigational Bispecific Tie2 Agonist/VEGF Inhibitor, for the Treatment of Neovascular Age-Related Macular Degeneration March 30, 2026 MSD’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins View all [H2] Media contact details Global media relations +1 908-740-5633 mediarelations@msd.com [H2] Media library Assets intended for use by media professionals. These images are downloadable for non-commercial use and for purposes such as news reporting or research. The images may not be modified and must display the following copyright language: Copyright © 2026 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. Learn more about MSD’s copyright and trademark policies. [H2] MSD corporate and product multimedia LogosPhotographyVideos [H3] Corporate brand [IMG: MSD logo] [H5] MSD logo Download [H3] Leadership [IMG: Photo of Rob Davis] [H5] Robert M. Davis Download [H3] Manufacturing [IMG: Automated visual inspection of filled vials] [H5] Automated visual inspection of filled vials Download [IMG: Automated visual inspection of filled vials] [H5] Automated visual inspection of filled vials Download [H3] Headquarters, research and manufacturing [IMG: MSD logo on building] [H5] B-roll package Download [H3] Vaccine production [IMG: Vaccine production line] [H5] B-roll package Download [IMG: Featured banner image] [H3] Get to know us through our stories Everything we do, in and out of the laboratory, is based on our deep appreciation for life. Get a glimpse of what it’s like on the inside through our stories. Read on [IMG: Scientist reviewing test tubes] [H3] We are driven by a single purpose We use the power of leading-edge science to save and improve lives around the world. Learn more about our company × [IMG: Person reviewing product pipeline on their smartphone] [H3] Pipeline Our pipeline shows our relentless pursuit of the next breakthrough. View our pipeline × [IMG: Employees sitting in lobby] [H3] Company fact sheet Access company information including stock ticker, official company names, description and more See company fact sheet ×
3744 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
28Review mentions (all pages)
4External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 7 | 1 |
| /company-overview/ | 5 | 1 |
| /company-overview/sustainability/ | 7 | 1 |
| /media/ | 9 | 1 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.msd.com/",
"url": "https://www.msd.com/",
"name": "MSD | Home",
"isPartOf": {
"@id": "https://www.msd.com/#website"
},
"datePublished": "2026-02-20T05:21:24+00:00",
"dateModified": "2026-05-29T13:14:35+00:00",
"description": "At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.",
"breadcrumb": {
"@id": "https://www.msd.com/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.msd.com/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://www.msd.com/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "MSD | Home"
}
]
},
{
"@type": "WebSite",
"@id": "https://www.msd.com/#website",
"url": "https://www.msd.com/",
"name": "MSD",
"description": "Just another vip2-msd.com site",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.msd.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
}
]
}
/company-overview/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.msd.com/company-overview/",
"url": "https://www.msd.com/company-overview/",
"name": "Who we are - MSD",
"isPartOf": {
"@id": "https://www.msd.com/#website"
},
"datePublished": "2020-04-03T15:09:22+00:00",
"dateModified": "2026-01-07T22:17:08+00:00",
"description": "MSD aspires to be the premier research-intensive biopharmaceutical company in the world. Learn about our commitment to save and improve lives.",
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.msd.com/company-overview/"
]
}
]
},
{
"@type": "WebSite",
"@id": "https://www.msd.com/#website",
"url": "https://www.msd.com/",
"name": "MSD",
"description": "Just another vip2-msd.com site",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.msd.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
}
]
}
/company-overview/sustainability/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.msd.com/company-overview/sustainability/",
"url": "https://www.msd.com/company-overview/sustainability/",
"name": "Sustainability - MSD",
"isPartOf": {
"@id": "https://www.msd.com/#website"
},
"datePublished": "2020-04-03T15:19:25+00:00",
"dateModified": "2026-03-02T15:11:13+00:00",
"description": "MSD corporate responsibility is about the health, social, environmental and economic impact on people and communities around the world.",
"breadcrumb": {
"@id": "https://www.msd.com/company-overview/sustainability/#breadcrumb"
},
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.msd.com/company-overview/sustainability/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://www.msd.com/company-overview/sustainability/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Who we are",
"item": "https://www.msd.com/company-overview/"
},
{
"@type": "ListItem",
"position": 2,
"name": "Sustainability"
}
]
},
{
"@type": "WebSite",
"@id": "https://www.msd.com/#website",
"url": "https://www.msd.com/",
"name": "MSD",
"description": "Just another vip2-msd.com site",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.msd.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
}
]
}
/media/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.msd.com/media/",
"url": "https://www.msd.com/media/",
"name": "Media - MSD",
"isPartOf": {
"@id": "https://www.msd.com/#website"
},
"primaryImageOfPage": {
"@id": "https://www.msd.com/media/#primaryimage"
},
"image": {
"@id": "https://www.msd.com/media/#primaryimage"
},
"thumbnailUrl": "https://www.msd.com/wp-content/uploads/sites/9/2020/08/02852_MSD_Logo_Horizontal_TealGrey.png?w=1024",
"datePublished": "2020-04-02T22:13:52+00:00",
"dateModified": "2026-04-20T12:13:17+00:00",
"description": "MSD's online newsroom offers real-time news about MSD's prescription medicines, vaccines and consumer care products.",
"inLanguage": "en-US",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.msd.com/media/"
]
}
]
},
{
"@type": "ImageObject",
"inLanguage": "en-US",
"@id": "https://www.msd.com/media/#primaryimage",
"url": "https://www.msd.com/wp-content/uploads/sites/9/2020/08/02852_MSD_Logo_Horizontal_TealGrey.png",
"contentUrl": "https://www.msd.com/wp-content/uploads/sites/9/2020/08/02852_MSD_Logo_Horizontal_TealGrey.png",
"width": 3055,
"height": 1436,
"caption": "MSD logo"
},
{
"@type": "WebSite",
"@id": "https://www.msd.com/#website",
"url": "https://www.msd.com/",
"name": "MSD",
"description": "Just another vip2-msd.com site",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.msd.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-US"
}
]
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Information Density
0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence
0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof
0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint
0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority
0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score
0 / 100
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Information Density
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Semantic Alignment
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Trust & Proof
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Commodity Fingerprint
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Identity & Authority
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS
Based on 784 businesses audited.
BS Detector
Medical Devices, Pharma & Biotech BS: MSD (Merck & Co., Inc.) (msd.com)
https://msd.com
📍 Industry: Medical Devices, Pharma & Biotech
22
BS / 100
MSD presents a fortress of technical substance and financial transparency wrapped in a standard big-pharma cliché shell. The site successfully avoids the ‘all-fluff’ trap by grounding global purpose in specific clinical trial names and audited sustainability metrics. Only minor technical laziness in the schema and heavy reliance on value-prop clichés prevent a perfect score.
Info Density
Power-words vs. Substance ratio.
7
23% BS
Semantic Coherence
Homepage promise vs. Sub-page reality.
2
10% BS
Trust & Proof
Verifiable evidence vs. Trust Theatre.
1
5% BS
Commodity Fingerprint
Detection of industry clichés/templates.
9
60% BS
Identity & Authority
Expert verifiability & Schema depth.
3
20% BS
First, remove the ‘Just another vip2-msd.com site’ boilerplate from the JSON-LD schema to reflect professional authority. Second, implement Person schema for all leadership members on the media and overview pages to verify their professional footprints. Third, replace the repeated ‘leading-edge science’ phrase in H2 headings with specific therapeutic areas or technology names to improve scannable substance. Fourth, link the internal ‘review_count’ metrics to external validation sources or patient advocacy ratings to eliminate ambiguity.
The website perfectly matches the Medical Devices, Pharma & Biotech category. It focuses on oncology research, biopharmaceutical manufacturing, and global health impact through specific programs like Mectizan and MSD for Mothers.
“The score of 22 is driven primarily by high Information Density and strong Semantic Coherence. While the Commodity Fingerprint is high due to standard industry jargon, the site's ability to provide dated, specific evidence (clinical trials and financial results from April/May 2026) significantly lowers the BS score.”
Verified Analysis Date: May 31, 2026
© 1EuroSEO Independent Evaluator — Non-Sponsored Result
Analysis Disclosure & Source Attribution
This training module utilizes a snapshot of public data from MSD (Merck & Co., Inc.), captured on May 31, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to MSD (Merck & Co., Inc.): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://msd.com to view the most current version of its content and learn from the source what this company is about and what it offers.